Randomized controlled trial of yogic meditation techniques for patients with obsessive-compulsive disorder

CNS Spectrums

Volumn 4, Issue 12, 1999, Pages 34-47

  Shannahoff Khalsa, David S ^a   Ray, Leslie E ^a   Levine, Saul ^a   Gallen, Christopher C ^a   Schwartz, Barry J ^a   Sidorowich, John J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; MALE; MEDITATION; MOOD; OBSESSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; STRESS; YOGA;

EID: 0033429190     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900006805     Document Type: Article

References (39)

1. Rapoport JL. The waking nightmare: an overview of obsessive compulsive disorder. J Clin Psychiatry. 1990;51:25-28.
2. Rasmussen SA, Eisen JL. Epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1990;51:10-13.
3. Jenike MA. Psychotherapy of the patient with obsessive compulsive personality disorder. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Theory and Management, St Louis, Mo: Mosby Year Book; 1990.
4. Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992;53:29-37.
5. Jenike MA. Pharmacologie treatment of obsessive compulsive disorders. Psychiatr Clin North Am. 1992;15:895-919.
6. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry. 1989;46:1006-1011.
7. Goodman WK, McDougle CJ, Barr LC, Aronson SC, Price LH. Biological approaches to treatment-resistant obsessive compulsive disorder. J Clin Psychiatry. 1993;54:16-26.
8. Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry. 1988;145:1521-1525.
9. Leonard HL, et al. A double-blind substitution during long-term clomipramine treatment in children and adolescents. Arch Cen Psychiatry. 1991;48:922-927.
10. Fontaine R, Chouinard G. Fluoxetine in the long-term treatment of obsessive compulsive disorder. Psychiatr Ann. 1989;19:88-91.
11. Kobak KA, Griest JH, Jefferson JW, Katzelnick DJ, Henk HJ. Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psyche-pharmacology. 1998;136:205-216.
12. 0'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. J Clin Psychiatry. 1991;52:150-155.
13. Marks IM. Review of behavioral psychotherapy. Am J Psychiatry. 1981;138:584-592.
14. Shannahoff-Khalsa DS, Beckett LR. Clinical case report: efficacy of yogic techniques in the treatment of obsessive compulsive disorder. Int J A'eurosci. 1996;85:1-17.
15. Derogatis LR. Symptom Checklist-90-Revised. Minneapolis, Minn: National Computer Systems; 1993.
16. Shannahoff-Khalsa DS. Yogic meditation techniques are effective in the treatment of obsessive compulsive disorders. In: Hollander E, Stein D, eds. Obsessive Compulsive Disorders: Etiology, Diagnosis, and Treatment. NewYork, NY: Marcel Dekker; 1997:283-329.
17. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. Washington, DC: American Psychiatric Association; 1987.
18. Shannahoff-Khalsa DS. Stress technology medicine: a new paradigm for stress and considerations for self-regulation. In: Brown MR, Koob G, Rivier C, eds. Stress: Neurobiology and Neuroendocrinology. New York, NY: Marcel Dekker; 1991:647-679.
19. Benson H. The Relaxation Response. New York, NY: Morrow; 1975.
20. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982;4:37-47.
21. Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. New York, NY: Delacorte Press; 1990.
22. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ. Computer-administered clinical rating scales: a review. Psychopharmacology. 1996; 12 7:291-301.
23. McNair DM, Lorr M, Droppleman LF. Profile of Moods Scale. San Diego, Calif: Educational and Industrial Testing Service; 1971.
24. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress: Perceived Stress Scale, The Journal of Health and Human Behaiior. 1983;24:386-396.
25. Crumbaugh JC, Maholick LT. Purpose in Life Test, Test 168, Form A. Murfreesboro, Tenn: Psychometric Affiliates; 1976.
26. Woody SR, Steketee G, Chambless DL. Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale. Behav Res Ther. 1995;33:597-605.
27. Woody SR, Steketee G, Chambless DL. The usefulness of the obsessive-compulsive scale of the Symptom Checklist-90-Revised. Behav Ther. 1995;33:607-611.
28. Werntz DA, Bickford RG, Shannahoff-Khalsa DS. Selective hemispheric stimulation by unilateral forced nostril breathing. Human Neuwbiology. 1987;6:165-171.
29. Shannahoff-Khalsa DS, Boyle MR, Buebel M. The effects of unilateral forced nostril breathing on cognition. Int J Neurosci. 1991;57:239-249.
30. Jella SA, Shannahoff-Khalsa DS. The effects of unilateral forced nostril breathing on cognitive performance. Int J Neurosci. 1993;73:61-68.
31. Schiff BB, Rump SA. Asymmetrical hemispheric activation and emotion: the effects of unilateral forced nostril breathing. Brain and Cognition. 1995;29:217-231.
32. Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53:595-606.
33. Goodman WK, Kozak MJ, Liebowitz M, White KL. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicenter, double-blind, placebo-controlled trial. Int Clin Psychopharmacol. 1996;ll:21-29.
34. Griest JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE. Clomipramine and obsessivecompulsive disorder: a placebo-controlled double-blind study of 32 patients. J Clin Psychiatry. 1990;51:292-297.
35. Griest JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:53-60.
36. Marks IM. Review of behavioral psychotherapy. Am J Psychiatry. 1981;138:584-592.
37. Baer L. Getting Control: Overcoming Your Obsessions and Compulsions. Boston, Mass: Little, Brown & Co; 1991.
38. Cottraux J. Behavioral psychotherapy for obsessive compulsive disorder. International Review of Psychiatry. 1989;l:227-234.
39. Baer L, Minichiello WE. Behavior therapy for obsessive compulsive disorder. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Theory and Management. St Louis, Mo: Mosby Year Book; 1990.